Novel Protein 'C5orf30' to Aid Treatment for Patients Suffering from Rheumatoid Arthritis

Increasing the levels of a new protein C5orf30 in the joints might be a novel method of reducing tissue damage caused by rheumatoid arthritis (RA).

A new protein is being identified by researchers which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints of the feet, hips, knees, and hands.

Following the discovery, RA patients most likely to suffer the severest effects of the condition can now be identified early and fast-tracked to the more aggressive treatments available.

Rheumatoid Arthritis Drug Restores Skin Color in Vitiligo Patient Without Any Side Effects
Treatment with the drug tofacitinib, a drug used for treating rheumatoid arthritis, may turn out to be a boon for patients suffering from vitiligo.

"Our findings provide a genetic marker that could be used to identify those RA patients who require more aggressive treatments or personalized medicine," said lead researcher Gerry Wilson, honorary professor at the University of Sheffield in Britain.

Although there is no cure for RA, new effective drugs are increasingly available to treat the disease and prevent deformed joints.

Self-management of the condition by patients, including exercise, is also known to reduce pain and resulting disability.

New Rheumatoid Arthritis Treatment Targets Underlying Cause, Not Just Symptoms
A rheumatoid arthritis treatment that aims at re-educating the immune system to look at the underlying cause of the disease has been designed by researchers.

The protein that the researchers identified is called C5orf30.

"They (the findings) also point to the possibility that increasing the levels of C5orf30 in the joints might be a novel method of reducing tissue damage caused by RA," Wilson noted.

Spine Surgery Reduces Pain Associated With Rheumatoid Arthritis in 82-Year-Old Patient
Doctors in Mumbai diagnosed a form of Rheumatoid Arthritis and conducted minimal invasive surgery to prevent vertebral stiffness in an elderly patient.

The researchers analyzed DNA samples and biopsy samples from the joints of over 1,000 RA patients in Sheffield and Ireland.

"These exciting findings will prompt us to further explore the role of this highly conserved protein that we know so little about, and its significance in human health and disease," study co-author Munitta Muthana from the University of Sheffield noted.

Rheumatoid Arthritis Treatment Widens With the Launch of New Products
GlobalData believes that the market expansion for RA treatment will be driven by increased RA prevalence.

The findings were detailed in the scientific journal PNAS.

Source-IANS